Corresponding author email: mmylonak@vet.auth.gr O BJECTIVES : To further clarify the causes of pancytopoenia and to investigate whether underlying cause or severity were associated with survival in an area endemic for vector-borne pathogens.
INTRODUCTION
Canine pancytopoenia is associated with a wide variety of causes including, but not limited to, infectious, neoplastic, immunemediated diseases and drug-induced blood cell dyscrasias (Weiss 2003 , Kearns & Ewing 2006 , Weiss 2012 . A thorough history and a systematic clinical and laboratory evaluation are therefore essential for a case-specific diagnosis (Kearns & Ewing 2006 ) . To our knowledge, only a single retrospective study addressing the prevalence of pancytopoenia and the relative frequency of the underlying causes in dogs admitted to a veterinary teaching hospital in the USA has been previously published (Weiss et al. 1999 ) . In that study, pancytopoenia was documented in 2·4% of the requested complete blood counts (CBC). Chemotherapyassociated pancytopoenia accounted for 46% of the cases, while infections (granulocytic ehrlichiosis/anaplasmosis, parvovirus infection, sepsis) were infrequently involved.
However, it may be considered that, in canine populations residing in geographic areas endemic for infectious agents known to cause various cytopoenias, such as Ehrlichia canis and Leishmania infantum , the relative frequency of the diseases precipitating pancytopoenia could be different, which may have clinical impli-cations (Mylonakis et al. 2004 , Petanides et al. 2008 . In addition, in the case series reported by Weiss et al. ( 1999 ) , the majority of pancytopoenic dogs were middle-or old-aged and breeds such as golden retriever and Labrador retriever were overrepresented, possibly as a result of the large proportion of oncologic cases and the breed-associated risk for various cancers. However, these epidemiological variables may be different in canine populations at risk for certain infectious diseases. For instance, several clinical studies indicate that German shepherds are more susceptible to E. canis infection, presenting increased morbidity and mortality (Nyindo et al. 1980 , Mylonakis et al. 2004 , while canine parvoviral enteritis (PE) mostly affects puppies under six months of age (Kalli et al. 2010 ) . Moreover, the potential association between the underlying diseases or the severity of pancytopoenia with the clinical outcome has yet to be investigated.
The objective of this study was to further define the causes of canine pancytopoenia in dogs originating from an area highly endemic for vector-borne pathogens, to explore potentially useful laboratory discriminators among the implicated causes, and to investigate if the underlying cause or the severity of pancytopoenia were associated with survival.
MATERIALS AND METHODS
Criteria for selection of cases Hard-copy medical records of all dogs admitted to Companion Animal Clinic, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece, between January 1, 2005 and June 30, 2013, were retrospectively searched and cases with pancytopoenia were identified as documented by a veterinary impedance or flow cytometry haematology analyser. For the purposes of the present study, pancytopoenia had to be documented on admission or during hospitalisation and was defined as the combination of low haematocrit (HCT, <37% for dogs older than five months or <30% for dogs younger than five months), white blood cell counts (WBC, <6×10 9 /L) and platelet (<200×10 9 /L) counts (Weiss et al. 1999 ) . Cases with incomplete medical records that lacked a final diagnosis, or dogs in which large platelet aggregates were observed in manual evaluation of stained blood smears were excluded from the study. To identify potential risk factors for pancytopoenia, a control group of dogs without blood cytopoenias, was also generated from the same hospital population. For every dog with pancytopoenia (case), two dogs without pancytopoenia (controls) were assigned. The two controls represented the temporally closest admissions before and following the admission of the case, respectively, that were subject to CBC examination, irrelevant of their health status.
Medical records review
The medical records of the dogs with pancytopoenia were reviewed individually and information on signalment, lifestyle, history, physical examination findings, clinicopathologic abnormalities, ancillary testing results (e.g. diagnostic imaging, molecular testing, endocrine testing), definitive diagnosis and outcome were retrieved. For dogs with serial CBC indicative of pancytopoenia, the first CBC report generated in the hospital was considered to be eligible for the study. Signalment data were also retrieved from the control dogs.
Diagnostic procedures
For the purposes of the present study, the diagnostic criteria for the underlying diseases associated with pancytopoenia are listed in Table 1 . Clinical outcome was defined as survival or non-survival (death or euthanasia due to disease-associated poor prognosis) to discharge from the hospital.
Statistical analysis
All comparisons of age, breed [purebred versus mixed-breed dogs and German shepherd versus non-German shepherd dogs (GSD)], sex, body weight and neutering status between the dogs with pancytopoenia and the controls were evaluated with a univariable-dependent logistic regression model. The mean values of HCT, WBC, platelet and total protein (TP) among the dogs with the most common diseases associated with pancytopoenia (i.e. monocytic ehrlichiosis, leishmaniasis, co-infections of ehrlichiosis and leishmaniasis, PE) were compared with one-way analysis of variance and Bonferroni correction for multiple comparisons. After plotting the histograms, the HCT, WBC and TP counts were normally distributed, while the platelet counts reached normality after log transformation. Finally, the variances between the groups were found constant with the Bartlett ' s test. The potential associations between the severity of pancytopoenia (mean HCT, WBC and platelet values), or the underlying disease (monocytic ehrlichiosis, leishmaniasis, PE and concurrent ehrlichiosis and leishmaniasis) and the dichotomous outcome (death or survival to discharge) were investigated with univariable logistic regression analysis. Statistical analyses were performed with a commercially available statistical software programme (Stata 13.1, StataCorp LP) and evaluated at the 0·05 level of significance.
RESULTS

Signalment of cases and controls
Two hundred and thirty-four dogs with pancytopoenia were retrieved from the archives. From these, 119 (50·9%) met the inclusion criteria. The signalment data of the pancytopoenic dogs and the 238 control dogs are summarised in Table 2 . Sex, body weight and genital status were matched between cases and controls. Mixed-breed dogs had odds of 1·90 [95% confidence interval (CI): 1·15 to 3·13] of being pancytopoenic compared to the purebreds (P=0·013) and dogs younger than one year had odds of 1·13 (95% CI: 1·04 to 1·21) of being pancytopoenic compared to the older dogs (P=0·001) ( Table 3 ) .
Causes and clinicopathologic findings in dogs with pancytopoenia
The disorders identified in the 119 pancytopoenic dogs are listed in Table 4 . The most common underlying diseases included monocytic ehrlichiosis, leishmaniasis, PE and concurrent ehrlichiosis and leishmaniasis. Significant differences were documented among dogs with common diseases, regarding the mean values of selected haematological and biochemical parameters (Fig 1 ) . Significantly lower (mean; 95% CI) HCT was found in dogs with monocytic ehrlichiosis (19·7%; 16·8 to 22·5%) compared to PE (28·1%; 25·5 to 30·7%), lower WBC counts in dogs with monocytic ehrlichiosis (2·50×10 9 /L; 1·89 to 3·12×10 9 /L) or PE (2·50×10 9 /L; 1·50 to 3·50×10 9 /L) compared to dogs with leishmaniasis (4·10×10 9 /L; 3·60 to 4·64×10 9 /L) and lower platelet counts in monocytic ehrlichiosis (32·88×10 9 /L; 22·18 to 43·59×10 9 /L); compared to dogs with leishmaniasis (114·57×10 9 /L; 95·73 to 133·41×10 9 /L), PE (94·26×10 9 /L; 69·00 to 119·52×10 9 /L) or concurrent monocytic ehrlichiosis and leishmaniasis (77·67×10 9 /L; 43·74 to 111·59×10 9 /L). In contrast, dogs with leishmaniasis had significantly higher values of WBC, platelets (PLT), and TP (8·83 g/L; 8·11 to 9·55g/L), while dogs with PE had the highest HCT values (28·1%, 25·5 to 30·7%) compared to the other diseases (Fig 1 ) .
Historically, four (3·5%) dogs had been treated with potentially myelosuppressive drugs within the previous month before presenting pancytopoenia; two were treated with phenobarbital (one was eventually diagnosed with monocytic ehrlichiosis) and two had been on multi-agent chemotherapy for multicentric lymphoma. The most prevalent clinical findings in dogs with pancytopoenia were tachypnoea (85/119, 71·4%), mucosal pallor (66/119, 55·5%), depression (56/119, 47%), lymph node enlargement (49/119, 41·2%) and bleeding tendency (48/119, 40·3%).
The most common serum biochemistry abnormalities included hypoalbuminaemia (68/96, 70·8%), hyponatraemia (42/68, 61·8%), elevated alkaline phosphatase (53/104, 51%) and alanine aminotransferase (31/108, 28·7%) activity, hyperbilirubinaemia (17/54, 31·5%), hyperproteinaemia (35/118, CI Confidence interval, CME Canine monocytic ehrlichiosis, CanL Canine leishmaniasis, PE Parvoviral enteritis * German shepherd dog † Variables that were found significant at the 0·05 level, suggesting that mixed-breed dogs had higher odds of being panytopoenic compared to the purebreds and younger dogs had higher odds of being pancytopoenic compared to the older dogs ‡ Median (range) age of dogs with CME, CanL and PE were 4·5 (0·2 to 13), 5 (1·5 to 14) and 0·2 (0·13 to 1) years, respectively 29·7%), elevated urea nitrogen (27/94, 28·7%) and hypoproteinaemia (31/118, 26·3%). Bone marrow aspiration and/or core biopsy specimens were examined in 42 of 119 (35·3%) pancytopoenic dogs. Bone marrow aplasia of all cell lineages was observed in 22 dogs (52·4%): 16 of 21 with monocytic ehrlichiosis, 2 of 2 with idiopathic aplastic anaemia, 2 of 3 with concurrent monocytic ehrlichiosis and leishmaniasis, 1 of 10 with leishmaniasis (a testicular seminoma was concurrently diagnosed and thought to be an incidental finding) and 1 of 1 with pyometra (Fig 2 ) . Myelophthisis was documented in two dogs [pure erythroid leukaemia (AML-M6b) and acute lymphoid leukaemia, respectively]. Severe hypoplasia of the megakaryocytic lineage was observed in a dog with leishmaniasis. Mild erythroid hypoplasia or hypoplasia of both the myeloid and megakaryocytic cell lines were observed in two and one dogs with monocytic ehrlichiosis, respectively. Cellularity was assessed as normal in one dog with dirofilariosis, one with phenobarbital-induced pancytopoenia and one with concurrent leishmaniasis, transmissible venereal tumour and multicentric lymphoma.
Clinical outcome
Outcome (death, euthanasia or survival to discharge from the hospital) could be retrieved for 90 (75·6%) pancytopoenic dogs. Thirty-two (35·5%) dogs died or were euthanased due to diseaseassociated poor prognosis (median time from admission to death or euthanasia: 1 day, range: 0 to 17 days), while 58 (65·5%) were discharged from the hospital (median duration of hospitalisation 1 day, range: 1 to 25 days). The association between the severity of pancytopoenia and the outcome indicated that an incremental trend of HCT (by at least one percentage unit) [OR (95% CI): 
DISCUSSION
Our results indicate that distinct infectious diseases, including monocytic ehrlichiosis and/or leishmaniasis and PE, may account for the vast majority of canine pancytopoenia cases in this geographic setting. The worldwide occurrence of PE and the fact that the vectors of E. canis and L. infantum are abundant in the Mediterranean region, Middle East and many (sub) tropical areas of the world, suggest that the information provided in this study may be of clinical relevance for veterinarians working in endemic areas. However, due to the movement of the hosts and animals to and from endemic areas, vector-borne diseases have been increasingly documented in other parts of the world, such as Central and Northern Europe (Harrus & Baneth 2005 ) . Dogs younger than one year had higher odds of being pancytopoenic compared to their older counterparts. This may be partially explained by the fact that PE, one of the major causes, has a strong age predilection, almost invariably affecting puppies less than six months old (Kalli et al. 2010 ) . In addition, dogs with aplastic pancytopoenia due to monocytic ehrlichiosis are usually of relatively young age (Mylonakis et al. 2004 ) . In the present study, the median age of dogs with monocytic ehrlichiosis, leishmaniasis or PE was 4·5, 5 and 0·2 years, respectively, while the median age of the controls was six years. Although breed-related susceptibility has been documented or suspected in previous studies for monocytic ehrlichiosis (GSD), leishmaniasis (GSD, boxer, rottweiler) and PE (rottweiler) (Mylonakis et al. 2004 , Saridomichelakis 2009 , Kalli et al. 2010 , mixed-breed dogs appeared at higher odds of being pancytopoenic compared to purebreds in this present study.
Canine monocytic ehrlichiosis was the leading cause of pancytopoenia, accounting for 40·3 and 50·4% of the cases, when considered singly or in co-occurrence with leishmaniasis, respectively. Persistent and profound pancytopoenia in the context of bone marrow multi-lineage aplasia (as observed in 17/21 dogs with monocytic ehrlichiosis subject to bone marrow cytological evaluation) is the hallmark of the chronic aplastic pancytopoenia typifying the myelosuppressive monocytic ehrlichiosis (Mylonakis et al. 2004 , Shipov et al. 2008 , Mylonakis et al. 2011 . A remarkable observation was that the mean HCT, WBC and platelet values of the dogs with monocytic ehrlichiosis in this study were significantly lower compared to those of the other prominent causes of pancytopoenia (leishmaniasis and PE). However, this finding should be interpreted cautiously and with the clear understanding, that substantiating differences on the average blood cell values is not of direct diagnostic utility and does not negate the need for disease-specific testing. The value of these trends to difference require further evaluation through sensitivity and specificity testing. The profound pancytopoenia of the dogs with monocytic ehrlichiosis probably implies that several of those dogs had chronic aplastic pancytopoenia, although not all dogs (21/42) were subject to bone marrow cytological evaluation to confirm this hypothesis. On the other hand, a transient mild-to-moderate pancytopoenia with normocellular bone marrow may occasionally occur in the acute monocytic ehrlichiosis (as found in 2/21 dogs described herein), which unlike aplastic pancytopoenia is well responsive to treatment and does not adversely affect prognosis (Mylonakis et al. 2011 ) .
Pancytopoenia has been inconsistently reported in leishmaniasis, with 0 to 12% of the affected dogs being pancytopoenic on admission , Petanides et al. 2008 , De Tommasi et al. 2014 . Evidence provided in this study suggests that, in endemic areas, leishmaniasis may account for 23·5 and 33·6% of pancytopoenic dogs, when considered singly or in co-occurrence with monocytic ehrlichiosis, respectively. The underlying bone marrow pathology in leishmaniasis-associated pancytopoenia has yet to be fully elucidated. In previous studies in dogs with leishmaniasis and various blood mono-or bicytopoenias, bone marrow changes included myeloid hyperplasia, erythroid hypoplasia, erythrophagocytosis, mild-to-moderate dysplastic changes affecting all three haematopoietic lineages, megakaryocytic emperipolesis, lymphocytosis and plasmacytosis, but generalised bone marrow aplasia was not documented (Foglia Manzillo et al. 2006 , Nicolato et al. 2013 , De Tommasi et al. 2014 . In the present study, 8 of 10 dogs with leishmaniasis subject to bone marrow cytology examination were normocellular, one demonstrated severe megakaryocytic aplasia and a single dog had severe aplasia of all three lineages. In the latter case, a coexistent testicular seminoma was thought to be an incidental finding as there was no clinical evidence of hyperoestrogenism (e.g. feminisation syndrome) and seminomas are very rarely involved in oestrogen myelotoxicity (Morgan 1982 ) . However, the possibility of a hormonally active neoplasm cannot entirely be ruled out because endogenous oestrogen concentrations were not measured. It appears, therefore, that unlike monocytic ehrlichiosis, aplastic pancytopoenia may be rare in leishmaniasis. The latter is probably reflected by the fact that the mean WBC and platelet values in dogs with leishmaniasis, were significantly higher compared to monocytic ehrlichiosis and PE, while the HCT was only mildly to moderately decreased. Hyperproteinaemia (noticed overall in 29·7% of the pancytopoenic dogs) is highly prevalent in leishmaniasis, typically reflecting a polyclonal activation and proliferation of B-lymphocytes , Petanides et al. 2008 . In agreement with a previous study , the mean TP concentration in leishmaniasis in the present study was significantly higher compared to monocytic ehrlichiosis and PE, offering a potentially useful diagnostic indicator.
Twelve pancytopoenic dogs had concurrent monocytic ehrlichiosis and leishmaniasis, which is not unexpected, taking into account the high rate of co-exposure and co-infection in endemic areas (Mekuzas et al. 2009 , Bourdeau et al. 2014 . Alternatively, depression of cell-mediated immunity in leishmaniasis may precipitate the clinical expression of an underlying infection, such as monocytic ehrlichiosis, although the reverse cannot be ruled out, leading a previously L. infantum -resistant dog to develop clinical disease (Saridomichelakis 2009 ). It is unclear whether concurrent monocytic ehrlichiosis and leishmaniasis could exacerbate the clinical and laboratory features of the infected dogs. Clinical signs tend to occur more frequently in dogs with dual as opposed to single-agent infections (Mekuzas et al. 2009 ). In this study, no significant differences were found regarding the HCT and WBC values in dual compared to single infections, but the platelet counts were significantly higher compared to dogs with monocytic ehrlichiosis alone, which may suggest that in this subset of dogs, the leishmaniasis rather than monocytic ehrlichiosis was the major clinical determinant. In contrast, two co-infected dogs had generalised bone marrow aplasia, assumed to primarily reflect the detrimental effect of monocytic ehrlichiosis. Since the clinical manifestations of monocytic ehrlichiosis and leishmaniasis tend to substantially overlap, any clinical discriminators might be of clinical relevance. In this respect, it was previously shown that mucosal pallor (55·5% of the dogs assessed herein) and overt bleeding tendency (40·3%) were strongly associated with monocytic ehrlichiosis, while peripheral lymphadenomegaly (41·2%) was strongly suggestive
